blog.biocommercialization.com — Discussion of the 2005 Patent Act of India, new Indian drug pricing policies, and evolving pharmaceuticals case law and current litigation in India. Related to these laws and policies, challenges to investing in Indian pharmaceutical technologies and biotechnologies are discussed.